A new study suggests that astrocytes, a type of brain cell, are important for connecting amyloid-β with the early stages of tau pathology, which could change how we define early Alzheimer’s disease.
Alzheimer’s: New blood biomarker may predict risk of cognitive decline
Posted in biotech/medical, neuroscience